COVID-19 inactivated vaccine products are packaged at a packaging plant of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, Dec. 25, 2020. (Xinhua/Zhang Yuwei)
The United Arab Emirates (UAE) based its nationwide immunization drive on the Chinese Sinopharm COVID-19 vaccine because of its early availability and the potential to produce shots locally, according to a report by Bloomberg.
"Sinopharm we felt very happy about. We have our own results," said Omar Najim, executive office director at Abu Dhabi's Department of Health.
The country entered talks with 23 companies and engaged with them over three main factors. Early procurement and purchasing were among the main considerations, while conducting local clinical trials and manufacturing the vaccine in the UAE were the other points of engagement.
The vaccine from Chinese drugmaker Sinopharm is the most widely used coronavirus vaccine in the UAE and showed an efficacy rate of 86 percent in local Phase 3 trials.
The UAE approved the vaccine after carrying out trials that involved 31,000 volunteers and it plans to begin manufacturing the vaccine this year.
Najim said the UAE had a delivery schedule on Sinopharm doses.
Award-winning photos show poverty reduction achievements in NE China's Jilin province
People dance to greet advent of New Year in Ameiqituo Town, Guizhou
Fire brigade in Shanghai holds group wedding
Tourists enjoy ice sculptures in Datan Town, north China
Sunset scenery of Dayan Pagoda in Xi'an
Tourists have fun at scenic spot in Nanlong Town, NW China
Harbin attracts tourists by making best use of ice in winter
In pics: FIS Alpine Ski Women's World Cup Slalom
Black-necked cranes rest at reservoir in Lhunzhub County, Lhasa
China's FAST telescope will be available to foreign scientists in April
